These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies. Necchi A; Raggi D; Gallina A; Madison R; Colecchia M; Lucianò R; Montironi R; Giannatempo P; Farè E; Pederzoli F; Bandini M; Bianchi M; Colombo R; Gandaglia G; Fossati N; Marandino L; Capitanio U; Dehò F; Ali SM; Chung JH; Ross JS; Salonia A; Briganti A; Montorsi F Eur Urol; 2020 Apr; 77(4):439-446. PubMed ID: 31708296 [TBL] [Abstract][Full Text] [Related]
9. Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study. Necchi A; Anichini A; Raggi D; Briganti A; Massa S; Lucianò R; Colecchia M; Giannatempo P; Mortarini R; Bianchi M; Farè E; Monopoli F; Colombo R; Gallina A; Salonia A; Messina A; Ali SM; Madison R; Ross JS; Chung JH; Salvioni R; Mariani L; Montorsi F J Clin Oncol; 2018 Dec; 36(34):3353-3360. PubMed ID: 30343614 [TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology. Vetterlein MW; Wankowicz SAM; Seisen T; Lander R; Löppenberg B; Chun FK; Menon M; Sun M; Barletta JA; Choueiri TK; Bellmunt J; Trinh QD; Preston MA Cancer; 2017 Nov; 123(22):4346-4355. PubMed ID: 28743155 [TBL] [Abstract][Full Text] [Related]
11. Micropapillary Bladder Cancer: Insights from the National Cancer Database. Sui W; Matulay JT; James MB; Onyeji IC; Theofanides MC; RoyChoudhury A; DeCastro GJ; Wenske S Bladder Cancer; 2016 Oct; 2(4):415-423. PubMed ID: 28035322 [No Abstract] [Full Text] [Related]
12. Predictors of Complete Pathologic Response (pT0) to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma. Pokuri VK; Syed JR; Yang Z; Field EP; Cyriac S; Pili R; Levine EG; Azabdaftari G; Trump DL; Guru K; George S Clin Genitourin Cancer; 2016 Feb; 14(1):e59-65. PubMed ID: 26508364 [TBL] [Abstract][Full Text] [Related]
13. Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder. Spaliviero M; Dalbagni G; Bochner BH; Poon BY; Huang H; Al-Ahmadie HA; Donahue TF; Taylor JM; Meeks JJ; Sjoberg DD; Donat SM; Reuter VE; Herr HW J Urol; 2014 Sep; 192(3):702-7. PubMed ID: 24603101 [TBL] [Abstract][Full Text] [Related]
14. Clinical Outcomes After Neoadjuvant Chemotherapy and Radical Cystectomy in the Presence of Urothelial Carcinoma of the Bladder With Squamous or Glandular Differentiation. Zargar-Shoshtari K; Sverrisson EF; Sharma P; Gupta S; Poch MA; Pow-Sang JM; Spiess PE; Sexton WJ Clin Genitourin Cancer; 2016 Feb; 14(1):82-8. PubMed ID: 26411593 [TBL] [Abstract][Full Text] [Related]
15. Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: the PRE-PREVENCYS trial. Hinsenveld FJ; Noordman BJ; Boormans JL; Voortman J; van Leenders GJLH; van der Pas SL; van Beek SC; Oprea-Lager DE; Vis AN BMC Cancer; 2021 Oct; 21(1):1161. PubMed ID: 34715822 [TBL] [Abstract][Full Text] [Related]
16. Optimization of Patient Selection for Neoadjuvant Chemotherapy in Muscle-invasive Urothelial Carcinoma of the Bladder. Hensley PJ; Goodwin J; Davenport DL; Strup SE; James A Clin Genitourin Cancer; 2018 Aug; 16(4):e851-e858. PubMed ID: 29548614 [TBL] [Abstract][Full Text] [Related]
17. Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter? Berg S; D'Andrea D; Vetterlein MW; Cole AP; Fletcher SA; Krimphove MJ; Marchese M; Lipsitz SR; Sonpavde G; Noldus J; Shariat SF; Kibel AS; Trinh QD; Mossanen M Cancer; 2019 May; 125(9):1449-1458. PubMed ID: 30620387 [TBL] [Abstract][Full Text] [Related]
18. Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer. Necchi A; Raggi D; Gallina A; Ross JS; Farè E; Giannatempo P; Marandino L; Colecchia M; Lucianò R; Bianchi M; Colombo R; Salonia A; Gandaglia G; Fossati N; Bandini M; Pederzoli F; Capitanio U; Montorsi F; de Jong JJ; Dittamore R; Liu Y; Davicioni E; Boormans JL; Briganti A; Black PC; Gibb EA Eur Urol; 2020 Jun; 77(6):701-710. PubMed ID: 32165065 [TBL] [Abstract][Full Text] [Related]